Biogen Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for neurological and other serious diseases. Key marketed products include LEQEMBI (Alzheimer's disease), SKYCLARYS (Friedreich's ataxia), and TYSABRI. The company also develops biosimilars and has a pipeline including felzartamab, litifilimab, and salanersen, with collaborations with partners such as Eisai and Supernus.
expected 2026-10-28
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-06 | 2025-12-31 | 0000875045-26-000013 | EDGAR | 110K words |
| 2025-02-12 | 2024-12-31 | 0000875045-25-000009 | EDGAR | — |
| 2024-02-14 | 2023-12-31 | 0000875045-24-000009 | EDGAR | — |
| 2023-02-15 | 2022-12-31 | 0000875045-23-000009 | EDGAR | — |
| 2022-02-03 | 2021-12-31 | 0000875045-22-000007 | EDGAR | — |
| 2021-02-03 | 2020-12-31 | 0000875045-21-000010 | EDGAR | — |
| 2020-02-06 | 2019-12-31 | 0000875045-20-000005 | EDGAR | — |
| 2019-02-06 | 2018-12-31 | 0000875045-19-000006 | EDGAR | — |
| 2018-02-01 | 2017-12-31 | 0000875045-18-000005 | EDGAR | — |
| 2017-02-02 | 2016-12-31 | 0000875045-17-000009 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-29 | 2026-06-30 | 0000875045-26-000075 | EDGAR | — |
| 2025-10-30 | 2025-09-30 | 0000875045-25-000049 | EDGAR | 60K words |
| 2025-07-31 | 2025-06-30 | 0000875045-25-000033 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000875045-25-000018 | EDGAR | — |
| 2024-10-30 | 2024-09-30 | 0000875045-24-000032 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000875045-24-000025 | EDGAR | — |
| 2024-04-24 | 2024-03-31 | 0000875045-24-000016 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000875045-23-000038 | EDGAR | — |
| 2023-07-25 | 2023-06-30 | 0000875045-23-000030 | EDGAR | — |
| 2023-04-25 | 2023-03-31 | 0000875045-23-000016 | EDGAR | — |
| 2022-10-25 | 2022-09-30 | 0000875045-22-000031 | EDGAR | — |
| 2022-07-20 | 2022-06-30 | 0000875045-22-000025 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-29 | 0000875045-26-000073 | EDGAR | — |
| 2026-04-06 | 0000875045-26-000039 | EDGAR | 1K words |
| 2026-03-31 | 0001193125-26-134889 | EDGAR | — |
| 2026-03-11 | 0000950157-26-000280 | EDGAR | — |
| 2026-02-11 | 0001193125-26-046803 | EDGAR | — |
| 2026-02-06 | 0000875045-26-000011 | EDGAR | — |
| 2026-01-14 | 0000875045-26-000003 | EDGAR | — |
| 2025-10-30 | 0000875045-25-000047 | EDGAR | — |
| 2025-10-14 | 0000875045-25-000040 | EDGAR | — |
| 2025-07-31 | 0000875045-25-000035 | EDGAR | — |
181 total filings indexed. 149 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000875045 |
| Ticker | BIIB |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.biogen.com |
| Listed | 1991-09-17 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BIIB (~200 tokens, structured JSON with cryptographic provenance)